FGFR Genomic Alterations and Response to Erdafitinib – Expert Commentary
Genetic alterations in fibroblast growth factor receptors (FGFRs), urothelial carcinoma, FGFR3 or FGFR2 genetic alterations, non-muscle invasive bladder cancer (NMIBC), muscle-invasive bladder cancer (MIBC).